Mostrar el registro sencillo del ítem

Artículo

dc.creatorAydillo, Teresaes
dc.creatorBalsera-Manzanero, Mariaes
dc.creatorRojo-Fernandez, Amayaes
dc.creatorEscalera, Albaes
dc.creatorSalamanca Rivera, Celiaes
dc.creatorPachón Díaz, Jerónimoes
dc.creatorMuñoz-García, María Del Mares
dc.creatorSánchez-Cordero, María Josées
dc.creatorSanchez Cespedes, Javieres
dc.creatorGarcía-Sastre, Adolfoes
dc.creatorCordero Matia, María Elisaes
dc.date.accessioned2024-05-20T12:01:34Z
dc.date.available2024-05-20T12:01:34Z
dc.date.issued2023
dc.identifier.issn2222-1751es
dc.identifier.urihttps://hdl.handle.net/11441/158662
dc.description.abstractCurrent clinical guidelines support the concomitant administration of seasonal influenza vaccines and COVID-19 mRNA boosters vaccine. Whether dual vaccination may impact vaccine immunogenicity due to an interference between influenza or SARS-CoV-2 antigens is unknown. We aimed to understand the impact of mRNA COVID-19 vaccines administered concomitantly on the immune response to influenza vaccines. For this, 128 volunteers were vaccinated during the 22-23 influenza season. Three groups of vaccination were assembled: FLU vaccine only (46, 35%) versus volunteers that received the mRNA bivalent COVID-19 vaccines concomitantly to seasonal influenza vaccines, FluCOVID vaccine in the same arm (42, 33%) or different arm (40, 31%), respectively. Sera and whole blood were obtained the day of vaccination, +7, and +28 days after for antibody and T cells response quantification. As expected, side effects were increased in individuals who received the FluCOVID vaccine as compared to FLU vaccine only based on the known reactogenicity of mRNA vaccines. In general, antibody levels were high at 4 weeks post-vaccination and differences were found only for the H3N2 virus when administered in different arms compared to the other groups at day 28 post-vaccination. Additionally, our data showed that subjects that received the FluCOVID vaccine in different arm tended to have better antibody induction than those receiving FLU vaccines for H3N2 virus in the absence of pre-existing immunity. Furthermore, no notable differences in the influenza-specific cellular immune response were found for any of the vaccination groups. Our data supports the concomitant administration of seasonal influenza and mRNA COVID-19 vaccines.es
dc.formatapplication/pdfes
dc.format.extent11 p.es
dc.language.isoenges
dc.publisherTaylor and Francis Groupes
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCOVID-19es
dc.subjectVaccinationes
dc.subjectInfluenzaes
dc.subjectMRNA vaccinees
dc.subjectSeasonal vaccinationes
dc.titleConcomitant administration of seasonal influenza and COVID-19 mRNA vaccineses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicina Preventiva y Salud Públicaes
dc.relation.projectIDP18-RT-3320es
dc.relation.projectIDCB21/13/00006es
dc.relation.projectID75N93019C00051es
dc.relation.projectID1034091es
dc.relation.projectID75N93021C00014es
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1080/22221751.2023.2292068es
dc.identifier.doi10.1080/22221751.2023.2292068es
dc.journaltitleEmerging Microbes and Infectionses
dc.publication.volumen13es
dc.publication.issue1es
dc.publication.initialPage2292068es
dc.contributor.funderConsejeria de Economia, Conocimiento, Empresas y Universidad, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spaines
dc.contributor.funderInstituto de Salud Carlos IIIes
dc.contributor.funderMinisterio de Ciencia e Innovacion and Union Europea - NextGeneration EUes
dc.contributor.funderSEM-CIVIC National Institute of Allergy and Infectious Diseaseses
dc.contributor.funderAmerican Lung Associationes
dc.contributor.funderCEIRR-CRIPTes
dc.contributor.funderCentro de Investigacion Biomedica en Red de Enfermedades Infecciosases
dc.contributor.funderCIBERINFECes
dc.description.awardwinningPremio Mensual Publicación Científica Destacada de la US. Facultad de Medicina

FicherosTamañoFormatoVerDescripción
Concomitant administration of ...5.350MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución-NoComercial 4.0 Internacional